A detailed history of Bnp Paribas Asset Management Holding S.A. transactions in Pfizer Inc stock. As of the latest transaction made, Bnp Paribas Asset Management Holding S.A. holds 2,769,596 shares of PFE stock, worth $76.1 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares
2,769,596
Previous 891,639 210.62%
Holding current value
$76.1 Million
Previous $24.7 Million 213.19%
% of portfolio
0.2%
Previous 0.07%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 29, 2024

BUY
$25.26 - $29.6 $47.4 Million - $55.6 Million
1,877,957 Added 210.62%
2,769,596 $77.5 Million
Q1 2024

May 08, 2024

SELL
$25.89 - $29.73 $42.1 Million - $48.3 Million
-1,625,461 Reduced 64.58%
891,639 $24.7 Million
Q4 2023

Feb 09, 2024

SELL
$26.13 - $33.94 $19.6 Million - $25.5 Million
-751,606 Reduced 22.99%
2,517,100 $72.5 Million
Q3 2023

Nov 13, 2023

BUY
$32.09 - $37.51 $50.3 Million - $58.8 Million
1,567,046 Added 92.09%
3,268,706 $108 Million
Q2 2023

Aug 08, 2023

SELL
$36.12 - $41.79 $27.9 Million - $32.2 Million
-771,185 Reduced 31.19%
1,701,660 $62.4 Million
Q1 2023

May 08, 2023

SELL
$39.39 - $51.28 $3.47 Million - $4.51 Million
-88,016 Reduced 3.44%
2,472,845 $101 Million
Q4 2022

Feb 09, 2023

SELL
$41.75 - $54.5 $14.5 Million - $18.9 Million
-346,909 Reduced 11.93%
2,560,861 $131 Million
Q3 2022

Nov 10, 2022

BUY
$43.76 - $53.42 $17 Million - $20.7 Million
388,298 Added 15.41%
2,907,770 $127 Million
Q2 2022

Aug 04, 2022

SELL
$46.53 - $55.17 $22.6 Million - $26.8 Million
-486,441 Reduced 16.18%
2,519,472 $132 Million
Q1 2022

May 12, 2022

BUY
$45.75 - $56.69 $22.1 Million - $27.4 Million
483,989 Added 19.19%
3,005,913 $156 Million
Q4 2021

Feb 09, 2022

BUY
$41.32 - $61.25 $44.4 Million - $65.9 Million
1,075,711 Added 74.38%
2,521,924 $149 Million
Q3 2021

Nov 08, 2021

SELL
$39.25 - $50.42 $32.4 Million - $41.6 Million
-824,954 Reduced 36.32%
1,446,213 $62.2 Million
Q2 2021

Aug 05, 2021

BUY
$35.91 - $40.68 $18.1 Million - $20.5 Million
505,153 Added 28.6%
2,271,167 $88.9 Million
Q1 2021

May 05, 2021

SELL
$33.49 - $37.77 $7.56 Million - $8.53 Million
-225,808 Reduced 11.34%
1,766,014 $64 Million
Q4 2020

Feb 12, 2021

SELL
$33.47 - $42.56 $2.45 Million - $3.11 Million
-73,119 Reduced 3.54%
1,991,822 $73.3 Million
Q3 2020

Nov 09, 2020

BUY
$31.75 - $37.25 $28.2 Million - $33.1 Million
889,371 Added 75.65%
2,064,941 $75.8 Million
Q2 2020

Aug 04, 2020

BUY
$30.12 - $36.54 $2.45 Million - $2.97 Million
81,398 Added 7.44%
1,175,570 $38.4 Million
Q1 2020

May 12, 2020

SELL
$27.03 - $38.62 $7.55 Million - $10.8 Million
-279,298 Reduced 20.34%
1,094,172 $35.7 Million
Q4 2019

Feb 11, 2020

SELL
$32.92 - $37.36 $11.2 Million - $12.7 Million
-339,795 Reduced 19.83%
1,373,470 $53.8 Million
Q3 2019

Nov 12, 2019

BUY
$32.49 - $42.13 $12.4 Million - $16.1 Million
381,608 Added 28.66%
1,713,265 $61.6 Million
Q2 2019

Aug 02, 2019

BUY
$36.98 - $41.52 $5.4 Million - $6.06 Million
145,969 Added 12.31%
1,331,657 $57.7 Million
Q1 2019

Apr 26, 2019

BUY
$37.5 - $41.2 $1.2 Million - $1.32 Million
32,106 Added 2.78%
1,185,688 $50.4 Million
Q4 2018

Feb 13, 2019

SELL
$38.47 - $43.86 $3.05 Million - $3.48 Million
-79,311 Reduced 6.43%
1,153,582 $49.6 Million
Q3 2018

Nov 13, 2018

BUY
$34.47 - $41.81 $6.07 Million - $7.36 Million
176,075 Added 16.66%
1,232,893 $54.3 Million
Q2 2018

Aug 01, 2018

BUY
$32.98 - $35.16 $2.83 Million - $3.02 Million
85,928 Added 8.85%
1,056,818 $38.3 Million
Q1 2018

May 07, 2018

SELL
$31.91 - $37.02 $2.56 Million - $2.97 Million
-80,106 Reduced 7.62%
970,890 $34.5 Million
Q4 2017

Feb 01, 2018

BUY
$33.26 - $35.29 $5.88 Million - $6.24 Million
176,829 Added 20.23%
1,050,996 $38.1 Million
Q3 2017

Nov 02, 2017

BUY
$31.0 - $34.15 $27.1 Million - $29.9 Million
874,167
874,167 $31.2 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $154B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Bnp Paribas Asset Management Holding S.A. Portfolio

Follow Bnp Paribas Asset Management Holding S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bnp Paribas Asset Management Holding S.A., based on Form 13F filings with the SEC.

News

Stay updated on Bnp Paribas Asset Management Holding S.A. with notifications on news.